The Comparative Safety and Effectiveness of Warfarin and Dabigatran Utilized in the Humana Non-Valvular Atrial Fibrillation Patient Population-A Retrospective Database Analysis (Safety of Dabigatran vs. Warfarin in NVAF Patients)

First published 10/09/2015

Last updated 20/10/2026

EU PAS number:

EUPAS10945

Study

Finalised

Download as PDF

Documents

Study protocol

No information provided.

Study results

1160-0192_Synopsis.pdf

English (276.79 KB - PDF) View document

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

The Comparative Safety and Effectiveness of Warfarin and Dabigatran Utilized in the Humana Non-Valvular Atrial Fibrillation Patient Population-A Retrospective Database Analysis (Safety of Dabigatran vs. Warfarin in NVAF Patients)

Secondary tabs

Share this page